Morning Breakouts

Latest California Healthline Stories

Lawmakers Should Remember ‘Lessons Learned’ from Medicare+Choice in Medicare Prescription Drug Benefit Debate

Congress should “keep in mind the lessons learned” from the “failed” Medicare+Choice program as they “struggle to reconcile House and Senate versions” of legislation to add a prescription drug benefit to Medicare, according to a Santa Rosa Press Democrat editorial.

FTC Attorneys to Appeal Decision in Schering-Plough Collusion Case

Attorneys at the Federal Trade Commission on Wednesday announced plans to appeal a decision issued last week by an FTC administrative law judge that dismissed antitrust charges against Schering-Plough Corp. and Upsher-Smith Laboratories, Bloomberg News/Philadelphia Inquirer reports.

New York Times Profiles ‘Real-Time’ Disease Reporting Systems

The New York Times yesterday profiled disease reporting systems that attempt to “collect and analyze disease data immediately,” rather than the current standard of once per day or more, which can delay detection of a disease outbreak.

New York Firm Targets Medical Transcription Services with Handheld Dictation Unit

A Syracuse, N.Y.-based developer of medical transcription applications has launched what it says is the first Palm handheld computer that digitally records physician dictation and transmits the data wirelessly for transcription, the Syracuse Post-Standard reports.

Judge Rules Schering-Plough Did Not Violate Antitrust Laws in Agreement With Generic Drug Maker

An administrative law judge at the Federal Trade Commission on Thursday ruled that Schering-Plough Corp. did not violate federal antitrust laws in an agreement to delay the introduction of a generic version of K-Dur 20, a treatment for the side effects of hypertension medications, the New York Times reports.